These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25019024)

  • 1. A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease.
    Kuro-O M
    Kidney Int Suppl (2011); 2013 Dec; 3(5):420-426. PubMed ID: 25019024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.
    Kuro-o M
    Nat Rev Nephrol; 2013 Nov; 9(11):650-60. PubMed ID: 23774819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
    Kuro-O M
    Clin Sci (Lond); 2021 Aug; 135(15):1915-1927. PubMed ID: 34374422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and FGF23-klotho system.
    Kuro-O M
    Vitam Horm; 2021; 115():317-332. PubMed ID: 33706952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate as a Pathogen of Arteriosclerosis and Aging.
    Kuro-O M
    J Atheroscler Thromb; 2021 Mar; 28(3):203-213. PubMed ID: 33028781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New Developments in CKD-MBD. Why is phosphate overload harmful?].
    Kuroo M
    Clin Calcium; 2014 Dec; 24(12):1785-92. PubMed ID: 25423923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder.
    Akiyama K; Kimura T; Shiizaki K
    Int J Endocrinol; 2018; 2018():5282389. PubMed ID: 29780418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts.
    Akiyama KI; Miura Y; Hayashi H; Sakata A; Matsumura Y; Kojima M; Tsuchiya K; Nitta K; Shiizaki K; Kurosu H; Kuro-O M
    Kidney Int; 2020 Apr; 97(4):702-712. PubMed ID: 32001068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression.
    Rutkowski JM; Pastor J; Sun K; Park SK; Bobulescu IA; Chen CT; Moe OW; Scherer PE
    Kidney Int; 2017 Feb; 91(2):324-337. PubMed ID: 27914707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers.
    Koeppert S; Ghallab A; Peglow S; Winkler CF; Graeber S; Büscher A; Hengstler JG; Jahnen-Dechent W
    Front Cell Dev Biol; 2021; 9():633925. PubMed ID: 33996793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
    Xie J; Yoon J; An SW; Kuro-o M; Huang CL
    J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the FGF23-Klotho axis.
    Kuro-o M
    Pediatr Nephrol; 2010 Apr; 25(4):583-90. PubMed ID: 19626341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
    Quarles LD
    Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.
    Disthabanchong S
    Int J Nephrol; 2018; 2018():3162806. PubMed ID: 29850246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.